| Citation Matrix | Glossary HistCite Guide |
|
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Staudt LM NEW ENGLAND JOURNAL OF MEDICINE 346 (25): 1937-1947 JUN 20 2002 and the citing papers |
Nodes: 134,
Authors: 594,
Sources: 80,
Outer References: 4803
Collection span: 2002 - 2004
View: Overview. Sorted by year, source, volume, issue, page.
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
|---|---|---|---|---|---|
| 1 | 1 | 37 | 1 2002 CANCER CELL 2(5):363-366
Staudt LM; Wilson WH Focus on lymphomas | 0 | 1 |
| 2 | 1 | 31 | 2 2002 CIRCULATION RESEARCH 91(7):559-564
Cook SA; Rosenzweig A DNA microarrays - Implications for cardiovascular medicine | 0 | 7 |
| 3 | 1 | 42 | 3 2002 CROATIAN MEDICAL JOURNAL 43(5):519-525
Kusec R Molecular and genetic mechanisms of lymphomagenesis | 0 | 0 |
| 4 | 1 | 36 | 4 2002 CROATIAN MEDICAL JOURNAL 43(5):535-540
Dominis M; Dzebro S; Gasparov S; Pesut A; Kusec R Diffuse large B-cell lymphoma and its variants | 0 | 1 |
| 5 | 1 | 1 | 5 2002 EUROPEAN JOURNAL OF CANCER 38(13):1674-1674
Cannell E Microarrays "predict survival from lymphoma" | 0 | 0 |
| 6 | 2 | 115 | 6 2002 EXPERT OPINION ON THERAPEUTIC PATENTS 12(12):1783-1794
Cullen P; Lorkowski S DNA micro-arrays in medicine: manufacturing techniques and potential applications | 0 | 0 |
| 7 | 1 | 149 | 7 2002 HISTOPATHOLOGY 41(6):482-509
Pileri SA; Dirnhofer S; Went P; Ascani S; Sabattini E; Marafioti T; Tzankov A; Leoncini L; Faliniu B; Zinzani PL Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification | 1 | 2 |
| 8 | 1 | 51 | 8 2002 JOURNAL OF BIOMEDICAL INFORMATICS 35(2):111-122
Sarkar IN; Planet PJ; Bael TE; Stanley SE; Siddall M; DeSalle R; Figurski DH Characteristic attributes in cancer microarrays | 0 | 0 |
| 9 | 1 | 3 | 9 2002 JOURNAL OF MOLECULAR MEDICINE-JMM 80(9):B6-B6
Rosenwald A Computer-assisted interpretation of hybridized microarrays - Molecular profiling to predict survival in lymphoma | 0 | 0 |
| 10 | 1 | 65 | 10 2002 NATURE GENETICS 32():474-479
Petricoin EF; Hackett JL; Lesko LJ; Puri RK; Gutman SI; Chumakov K; Woodcock J; Feigal DW; Zoon KC; Sistare FD Medical applications of microarray technologies: a regulatory science perspective | 0 | 16 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 11 | 1 | 50 | 11 2002 NATURE GENETICS 32():533-540
Chung CH; Bernard PS; Perou CM Molecular portraits and the family tree of cancer | 2 | 22 |
| 12 | 1 | 12 | 12 2002 NATURE MEDICINE 8(8):781-783
Longo DL DR's orders: Human antibody kills tumors by direct signaling | 0 | 1 |
| 13 | 1 | 106 | 13 2002 NATURE REVIEWS CANCER 2(10):740-749
Darnell JE Transcription factors as targets for cancer therapy | 0 | 24 |
| 14 | 1 | 82 | 14 2002 NATURE REVIEWS DRUG DISCOVERY 1(9):683-695
Petricoin EF; Zoon KC; Kohn EC; Barrett JC; Liotta LA Clinical proteomics: Translating benchside promise into bedside reality | 1 | 44 |
| 15 | 1 | 7 | 15 2002 NEUROLOGY 59(8):1128-1129
Thornton CA; Welle SL Molecular fingerprints of inflammatory myopathies | 0 | 2 |
| 16 | 0 | 17 | 16 2002 NEW ENGLAND JOURNAL OF MEDICINE 346(25):1937-1947
Rosenwald A; Wright G; Chan WC; Connors JM; Campo E; Fisher RI; Gascoyne RD; Muller-Hermelink HK; Smeland EB; Staudt LM The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma | 133 | 133 |
| 17 | 1 | 12 | 17 2002 NEW ENGLAND JOURNAL OF MEDICINE 346(25):1998-1999
Magrath I Molecular characteristics of diffuse large-B-cell lymphoma | 2 | 2 |
| 18 | 1 | 1 | 18 2002 NEW ENGLAND JOURNAL OF MEDICINE 347(17):1376-1376
Akhtar S Molecular profiling of lymphoma | 0 | 0 |
| 19 | 1 | 2 | 19 2002 NEW ENGLAND JOURNAL OF MEDICINE 347(17):1376-1377
Staudt LM Molecular profiling of lymphoma - Reply | 0 | 0 |
| 20 | 1 | 30 | 20 2002 PHARMACEUTICAL RESEARCH 19(12):1773-1778
Chin KV; Kong ANT Application of DNA Microarrays in pharmacogenomics and toxicogenomics | 0 | 2 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 21 | 1 | 56 | 21 2002 RADIOLOGE 42(12):936-+
Rudiger T; Muller-Hermelink HK WHO-classification of malignant lymphomas | 0 | 0 |
| 22 | 2 | 30 | 22 2003 AMERICAN JOURNAL OF PATHOLOGY 163(1):135-144
Pan ZG; Shen YL; Du C; Zhou GM; Rosenwald A; Staudt LM; Greiner TC; McKeithan TW; Chan WC Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells | 0 | 0 |
| 23 | 1 | 25 | 23 2003 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY 29(3):S32-S36
Kaminski N Microarray analysis of idiopathic pulmonary fibrosis | 0 | 0 |
| 24 | 1 | 46 | 24 2003 AMERICAN JOURNAL OF SURGICAL PATHOLOGY 27(3):356-364
Kim BK; Surti U; Pandya AG; Swerdlow SH Primary and secondary cutaneous diffuse large B-cell lymphomas - A multiparameter analysis of 25 cases including fluorescence in situ hybridization for t(14;18) translocation | 0 | 1 |
| 25 | 1 | 43 | 25 2003 AMERICAN JOURNAL OF SURGICAL PATHOLOGY 27(6):790-798
Kwon MS; Go JH; Choi JS; Lee SS; Ko YH; Rhee JC; Ree HJ Critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the stomach and small intestine | 0 | 0 |
| 26 | 1 | 50 | 26 2003 AMERICAN JOURNAL OF SURGICAL PATHOLOGY 27(7):919-928
Choi JS; Nam DH; Ko YH; Seo JW; Choi YL; Suh YL; Ree HJ Primary central nervous system lymphoma in Korea - Comparison of B-and T-cell lymphomas | 0 | 0 |
| 27 | 1 | 51 | 27 2003 ANNALS OF HEMATOLOGY 82(6):323-332
Schwaenen C; Wessendorf S; Kestler HA; Dohner H; Lichter P; Bentz M DNA microarray analysis in malignant lymphomas | 0 | 1 |
| 28 | 1 | 94 | 28 2003 ANNALS OF HEMATOLOGY 82(11):661-670
Maartense E; Kluin-Nelemans HC; Noordijk EM Non-Hodgkin's lymphoma in the elderly - A review with emphasis on elderly patients, geriatric assessment, and future perspectives | 0 | 0 |
| 29 | 1 | 278 | 29 2003 ANNUAL REVIEW OF IMMUNOLOGY 21():841-894
Chiorazzi N; Ferrarini M B cell chronic lymphocytic leukemia: Lessons learned from studies of the B cell antigen receptor | 1 | 7 |
| 30 | 1 | 88 | 30 2003 BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER 1603(2):99-111
Watters JW; McLeod HL Cancer pharmacogenomics: current and future applications | 0 | 5 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 31 | 1 | 18 | 31 2003 BIOINFORMATICS 19(6):686-693
LeBlanc M; Kooperberg C; Grogan TM; Miller TP Directed indices for exploring gene expression data | 0 | 1 |
| 32 | 1 | 8 | 32 2003 BIOINFORMATICS 19(18):2448-2455
Wright GW; Simon RM A random variance model for detection of differential gene expression in small microarray experiments | 0 | 0 |
| 33 | 2 | 9 | 33 2003 BIOTECHNIQUES ():16-+
Simon RM; Dobbin K Experimental design of DNA microarray experiments | 0 | 0 |
| 34 | 1 | 60 | 34 2003 BIOTECHNIQUES ():64-+
O'Neill GM; Catchpoole DR; Golemis EA From correlation to causality: Microarrays, cancer, and cancer treatment | 0 | 0 |
| 35 | 1 | 48 | 35 2003 BLOOD 101(1):78-84
Colomo L; Lopez-Guillermo A; Perales M; Rives S; Martinez A; Bosch F; Colomer D; Falini B; Montserrat E; Campo E Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma | 3 | 3 |
| 36 | 1 | 35 | 36 2003 BLOOD 101(2):433-440
Lossos IS; Alizadeh AA; Rajapaksa R; Tibshirani R; Levy R HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma | 2 | 3 |
| 37 | 1 | 231 | 37 2003 BLOOD 101(4):1220-1235
Sanchez-Beato M; Sanchez-Aguilera A; Piris MA Cell cycle deregulation in B-cell lymphomas | 0 | 7 |
| 38 | 1 | 50 | 38 2003 BLOOD 101(7):2789-2796
Nishikori M; Maesako Y; Ueda C; Kurata M; Uchiyama T; Ohno H High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin disease | 0 | 3 |
| 39 | 1 | 41 | 39 2003 BLOOD 101(11):4576-4582
Nasr R; Rosenwald A; El-Sabban ME; Arnulf B; Zalloua P; Lepelletier Y; Bex F; Hermine O; Staudt L; de The H; Bazarbachi A Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HILV-1-infected leukemic cells | 0 | 1 |
| 40 | 1 | 43 | 40 2003 BLOOD 101(12):4653-4659
Little RF; Pittaluga S; Grant N; Steinberg SM; Kavlick MF; Mitsuya H; Franchini G; Gutierrez M; Raffeld M; Jaffe ES; Shearer G; Yarchoan R; Wilson WH Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology | 1 | 9 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 41 | 1 | 52 | 41 2003 BLOOD 102(1):262-268
Ferrando AA; Armstrong SA; Neuberg DS; Sallan SE; Silverman LB; Korsmeyer SJ; Look AT Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation | 0 | 10 |
| 42 | 1 | 23 | 42 2003 BLOOD 102(1):324-327
de Jong D; Glas AM; Boerrigter L; Hermus MC; Dalesio O; Willemse E; Nederlof PM; Kersten MJ Very late relapse in diffuse large B-cell lymphoma represents clonally related disease and is marked by germinal center cell features | 1 | 1 |
| 43 | 1 | 37 | 43 2003 BLOOD 102(5):1849-1856
Yagi T; Morimoto A; Eguchi M; Hibi S; Sako M; Ishii E; Mizutani S; Imashuku S; Ohki M; Ichikawa H Identification of a gene expression signature associated with pediatric AML prognosis | 0 | 4 |
| 44 | 1 | 81 | 44 2003 BLOOD 102(8):2868-2876
Marafioti T; Jones M; Facchetti F; Diss TC; Du MQ; Isaacson PG; Pozzobon M; Pileri SA; Strickson AJ; Tan SY; Watkins F; Mason DY Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology | 0 | 0 |
| 45 | 1 | 38 | 45 2003 BLOOD 102(8):2951-2959
Ross ME; Zhou XD; Song GC; Shurtleff SA; Girtman K; Williams WK; Liu HC; Mahfouz R; Raimondi SC; Lenny N; Patel A; Downing JR Classification of pediatric acute lymphoblastic leukemia by gene expression profiling | 0 | 1 |
| 46 | 1 | 27 | 46 2003 BLOOD 102(13):4504-4511
Davies FE; Dring AM; Li C; Rawstron AC; Shammas MA; O'Connor SM; Fenton JAL; Hideshima T; Chauhan D; Tai IT; Robinson E; Auclair D; Rees K; Gonzalez D; Ashcroft AJ; Dasgupta R; Mitsiades C; Mitsiades N; Chen LB; Wong WH; Munshi NC; Morgan GJ; Anderson KC Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis | 0 | 0 |
| 47 | 1 | 12 | 47 2003 BMC BIOINFORMATICS 4():-
O'Neill MC; Song L Neural network analysis of lymphoma microarray data: prognosis and diagnosis near-perfect | 0 | 0 |
| 48 | 1 | 32 | 48 2003 BREAST CANCER RESEARCH AND TREATMENT 82(2):113-123
Assersohn L; Salter J; Powles TJ; A'hern R; Makris A; Gregory RK; Chang J; Dowsett M Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancer | 0 | 0 |
| 49 | 2 | 26 | 49 2003 BRITISH JOURNAL OF CANCER 89(9):1599-1604
Simon R Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data | 0 | 0 |
| 50 | 1 | 36 | 50 2003 BRITISH JOURNAL OF HAEMATOLOGY 123(4):621-630
Niitsu N; Nakamine H; Okamoto M; Akamatsu H; Honma Y; Higashihara M; Okabe-Kado J; Hirano M Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 51 | 1 | 21 | 51 2003 BULLETIN DU CANCER 90(2):127-130
Minvielle S Gene expression profiling of multiple myeloma | 0 | 0 |
| 52 | 1 | 30 | 52 2003 CANCER 98(3):516-521
Moller MB; Christensen BE; Pedersen NT Prognosis of localized diffuse large B-Cell lymphoma in younger patients - Predictive value of age-and stage-adjustment of the international prognostic index | 0 | 0 |
| 53 | 1 | 57 | 53 2003 CANCER CELL 3(2):185-197
Rosenwald A; Wright G; Wiestner A; Chan WC; Connors JM; Campo E; Gascoyne RD; Grogan TM; Muller-Hermelink HK; Smeland EB; Chiorazzi M; Giltnane JM; Hurt EM; Zhao H; Averett L; Henrickson S; Yang LM; Powell J; Wilson WH; Jaffe ES; Simon R; Klausner RD; Montserrat E; Bosch F; Greiner TC; Weisenburger DD; Sanger WG; Dave BJ; Lynch JC; Vose J; Armitage JO; Fisher RI; Miller TP; LeBlanc M; Ott G; Kvaloy S; Holte H; Delabie J; Staudt LM The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma | 3 | 17 |
| 54 | 1 | 39 | 54 2003 CANCER CYTOPATHOLOGY 99(6):385-393
Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun XP; Huh YO; Katz RL Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates - A comparison with flow cytometry immunophenotyping | 0 | 0 |
| 55 | 1 | 11 | 55 2003 CANCER GENETICS AND CYTOGENETICS 147(1):68-70
Wong KF; So CC Diffuse large B-cell lymphoma with occult marrow involvement and a novel t(9;10)(q32;q22) | 0 | 0 |
| 56 | 1 | 89 | 56 2003 CANCER INVESTIGATION 21(6):937-949
Luo J; Isaacs WB; Trent JM; Duggan DJ Looking beyond morphology: Cancer gene expression profiling using DNA microarrays | 0 | 0 |
| 57 | 1 | 28 | 57 2003 CANCER RESEARCH 63(16):5159-5164
Ishibashi Y; Hanyu N; Nakada K; Suzuki Y; Yamamoto T; Yanaga K; Ohkawa K; Hashimoto N; Nakajima T; Saito H; Matsushima M; Urashima M Profiling gene expression ratios of paired cancerous and normal tissue predicts relapse of esophageal squamous cell carcinoma | 0 | 0 |
| 58 | 1 | 33 | 58 2003 CANCER SCIENCE 94(9):774-781
Maesako Y; Uchiyama T; Ohno H Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B-cell lymphoma | 0 | 0 |
| 59 | 2 | 23 | 59 2003 CANCER SCIENCE 94(10):906-913
Ando T; Suguro M; Kobayashi T; Seto M; Honda H Multiple fuzzy neural network system for outcome prediction and classification of 220 lymphoma patients on the basis of molecular profiling | 0 | 0 |
| 60 | 1 | 49 | 60 2003 CLINICAL CANCER RESEARCH 9(2):722-728
Linderoth J; Jerkeman M; Cavallin-Stahl E; Kvaloy S; Torlakovic E Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: A Nordic Lymphoma Group study | 1 | 2 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 61 | 1 | 35 | 61 2003 CLINICAL CANCER RESEARCH 9(6):2133-2139
Barrans SL; Evans PAS; O'Connor SJM; Kendall SJ; Owen RG; Haynes AP; Morgan GJ; Jack AS The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome | 0 | 0 |
| 62 | 1 | 28 | 62 2003 CLINICAL CANCER RESEARCH 9(15):5486-5492
Wong YF; Selvanayagam ZE; Wei N; Porter J; Vittal R; Hu R; Lin Y; Liao J; Shih JW; Cheung TH; Lo KWK; Yim SF; Yip SK; Ngong DT; Siu N; Chan LKY; Chan CS; Kong T; Kutlina E; McKinnon RD; Denhardt DT; Chin KV; Chung TKH Expression Genomics of cervical cancer: Molecular classification and prediction of radiotherapy response by DNA microarray | 0 | 0 |
| 63 | 1 | 37 | 63 2003 CURRENT OPINION IN GENETICS & DEVELOPMENT 13(1):97-103
Liu ET Classification of cancers by expression profiling | 0 | 3 |
| 64 | 1 | 96 | 64 2003 CURRENT OPINION IN ONCOLOGY 15(1):36-43
Guo QM DNA microarray and cancer | 0 | 2 |
| 65 | 1 | 19 | 65 2003 CYTOMETRY PART B-CLINICAL CYTOMETRY 53B(1):1-3
Valet GK; Tarnok A Cytomics in predictive medicine | 0 | 2 |
| 66 | 1 | 41 | 66 2003 DRUG DISCOVERY TODAY 8(8):356-363
Huang Y; Sadee W Drug sensitivity and resistance genes in cancer chemotherapy: a chemogenomics approach | 0 | 1 |
| 67 | 1 | 21 | 67 2003 EPIGENETICS IN CANCER PREVENTION: EARLY DETECTION AND RISK ASSESSMENT 983():142-150
Barker PE Cancer biomarker validation: Standards and process - Roles for the National Institute of Standards and Technology (NIST) | 0 | 1 |
| 68 | 1 | 81 | 68 2003 EUROPEAN UROLOGY 44(4):390-400
Montironi R; Mazzucchelli R; Scarpelli M Molecular techniques and prostate cancer diagnostic | 0 | 0 |
| 69 | 1 | 299 | 69 2003 FRONTIERS IN BIOSCIENCE 8():D156-D175
Evens AM; Gartenhaus RB Molecular etiology of mature T-cell Non-Hodgkins lymphomas | 0 | 0 |
| 70 | 1 | 161 | 70 2003 HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA 17(6):1277-+
Smoller BR; Santucci M; Wood GS; Whittaker SJ Histopathology and genetics of cutaneous T-cell lymphoma | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 71 | 1 | 29 | 71 2003 HISTOPATHOLOGY 43(3):209-219
Zettl A; Meister S; Katzenberger T; Kalla J; Ott MM; Muller-Hermelink HK; Ott G Immunohistochemical analysis of B-cell lymphoma using tissue microarrays identifies particular phenotypic profiles of B-cell lymphomas | 0 | 0 |
| 72 | 1 | 45 | 72 2003 HISTOPATHOLOGY 43(4):323-331
Knosel T; Schluns K; Stein U; Schwabe H; Schlag PM; Dietel M; Petersen I Genetic imbalances with impact on survival in colorectal cancer patients | 0 | 0 |
| 73 | 4 | 161 | 73 2003 HISTOPATHOLOGY 43(6):509-528
de Leval L; Harris NL Variability in immunophenotype in diffuse large B-cell lymphoma and its clinical relevance | 0 | 0 |
| 74 | 1 | 47 | 74 2003 HUMAN PATHOLOGY 34(6):610-616
Ree HJ; Ohsima K; Aozasa K; Takeuchi K; Kim CW; Yang WI; Huh JY; Lee SS; Ko YH; Kwon MS; Cho EY; Choi YL; Rhee JC; Kikuchi M; Mori S Detection of germinal center B-cell lymphoma in archival specimens: Critical evaluation of bcl-6 protein expression in diffuse large B-cell lymphoma of the tonsil | 0 | 1 |
| 75 | 1 | 40 | 75 2003 HUMAN PATHOLOGY 34(12):1259-1264
Chiu KC; Fine M; Ikle D; Slovak ML; Arber DA Telomerase activity and proliferation index in aggressive mature B-cell lymphoma: Comparison to germinal center phenotypic markers | 0 | 0 |
| 76 | 1 | 50 | 76 2003 HYPERTENSION 41(1):3-8
Pravenec M; Wallace C; Aitman TJ; Kurtz TW Gene expression profiling in hypertension research - A critical perspective | 0 | 4 |
| 77 | 2 | 44 | 77 2003 INTERNATIONAL JOURNAL OF HEMATOLOGY 77(4):321-329
Lossos IS; Levy R Diffuse large B-cell lymphoma: Insights gained from gene expression profiling | 0 | 0 |
| 78 | 1 | 2 | 78 2003 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 289(2):155-+
Vastag B Gene chips inch toward the clinic | 0 | 1 |
| 79 | 1 | 20 | 79 2003 JOURNAL OF BIOSCIENCE AND BIOENGINEERING 96(2):161-167
Ando T; Suguro M; Kobayashi T; Seto M; Honda H Selection of causal gene sets for lymphoma prognostication from expression profiling and construction of prognostic fuzzy neural network models | 1 | 1 |
| 80 | 1 | 38 | 80 2003 JOURNAL OF BONE AND MINERAL RESEARCH 18(12):2190-2199
Guichelaar MMJ; Malinchoc M; Sibonga JD; Clarke BL; Hay JE Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 81 | 1 | 15 | 81 2003 JOURNAL OF CLINICAL PATHOLOGY 56(2):159-159
Pileri SA; Sabattini E; Ascani S; Zinzani PL; Falini B How do we define Hodgkin's disease? The authors' reply | 0 | 0 |
| 82 | 2 | 33 | 82 2003 JOURNAL OF CLINICAL PATHOLOGY 56(10):747-752
Tzankov A; Pehrs AC; Zimpfer A; Ascani S; Lugli A; Pileri S; Dirnhofer S Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases | 0 | 0 |
| 83 | 3 | 36 | 83 2003 JOURNAL OF EXPERIMENTAL MEDICINE 198(6):851-862
Rosenwald A; Wright G; Leroy K; Yu X; Gaulard P; Gascoyne RD; Chan WC; Zhao T; Haioun C; Greiner TC; Weisenburger DD; Lynch JC; Vose J; Armitage JO; Smeland EB; Kvaloy S; Holte H; Delabie J; Campo E; Montserrat E; Lopez-Guillermo A; Ott G; Muller-Hermelink HK; Connors JM; Braziel R; Grogan TM; Fisher RI; Miller TP; LeBlanc M; Chiorazzi M; Zhao H; Yang LM; Powell J; Wilson WH; Jaffe ES; Simon R; Klausner RD; Staudt LM Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma | 0 | 1 |
| 84 | 1 | 36 | 84 2003 JOURNAL OF INVESTIGATIVE DERMATOLOGY 120(5):865-870
Storz MN; van de Rijn M; Kim YH; Mraz-Gernhard S; Hoppe RT; Kohler S Gene expression profiles of cutaneous B cell lymphoma | 0 | 0 |
| 85 | 1 | 33 | 85 2003 JOURNAL OF MOLECULAR DIAGNOSTICS 5(2):113-120
Wang ZY; Zhang Q; Wilson J; Ratajczak MZ; Wasik MA Detection of protein tyrosine-kinase (PTK) gene expression pattern in normal and malignant T lymphocytes by combined PTK-specific polymerase chain reaction and parallel denaturing gradient gel electrophoresis | 0 | 0 |
| 86 | 1 | 82 | 86 2003 JOURNAL OF NUTRITION 133(7):2476S-2484S
Petricoin EF; Liotta LA Clinical applications of proteomics | 0 | 2 |
| 87 | 1 | 100 | 87 2003 JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS 197(1):127-141
Koniaris LG; Drugas G; Katzman PJ; Salloum R Management of gastrointestinal lymphoma | 0 | 0 |
| 88 | 1 | 22 | 88 2003 JOURNAL OF THE NATIONAL CANCER INSTITUTE 95(1):14-18
Simon R; Radmacher MD; Dobbin K; McShane LM Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification | 3 | 16 |
| 89 | 1 | 25 | 89 2003 JOURNAL OF THE NATIONAL CANCER INSTITUTE 95(8):598-605
Gordon GJ; Jensen RV; Hsiao LL; Gullans SR; Blumenstock JE; Richards WG; Jaklitsch MT; Sugarbaker DJ; Bueno R Using gene expression ratios to predict outcome among patients with mesothelioma | 0 | 2 |
| 90 | 1 | 42 | 90 2003 JOURNAL OF THE NATIONAL CANCER INSTITUTE 95(9):661-668
Rhodes DR; Sanda MG; Otte AP; Chinnaiyan AM; Rubin MA Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer | 0 | 5 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 91 | 1 | 69 | 91 2003 LABORATORY INVESTIGATION 83(3):305-316
Bertucci F; Viens P; Tagett R; Nguyen C; Houlgatte R; Birnbaum D DNA arrays in clinical oncology: Promises and challenges | 0 | 1 |
| 92 | 2 | 6 | 92 2003 LABORATORY MEDICINE 34(11):771-774
Woeste S Molecular profiling for cancer | 0 | 0 |
| 93 | 1 | 70 | 93 2003 LANCET 362(9378):139-146
Evans LS; Hancock BW Non-Hodgkin lymphoma | 0 | 0 |
| 94 | 1 | 25 | 94 2003 LEUKEMIA 17(4):789-795
Lossos IS; Czerwinski DK; Wechser MA; Levy R Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies | 0 | 2 |
| 95 | 1 | 37 | 95 2003 LEUKEMIA 17(5):972-977
Ribrag V; Koscielny S; Carpiuc I; Cebotaru C; Vande Walle H; Talbot M; Fenaux P; Bosq J Prognostic value of GST-pi expression in diffuse large B-cell lymphomas | 0 | 0 |
| 96 | 1 | 45 | 96 2003 LEUKEMIA 17(7):1390-1397
Lossos IS; Akasaka T; Martinez-Climent JA; Siebert R; Levy R The BCL6 gene in B-cell lymphomas with 3q27 translocations is expressed mainly from the rearranged allele irrespective of the partner gene | 0 | 0 |
| 97 | 1 | 103 | 97 2003 LEUKEMIA 17(10):1948-1960
Fisher RI; Shah P Current trends in large cell lymphoma | 0 | 0 |
| 98 | 1 | 23 | 98 2003 LEUKEMIA & LYMPHOMA 44():S1-S4
Hagenbeek A; Delaloye AB Editorial perspective - Advances in B-cell non-Hodgkin's lymphoma | 0 | 0 |
| 99 | 1 | 135 | 99 2003 LEUKEMIA & LYMPHOMA 44():S15-S27
Marcus R Current treatment options in aggressive lymphoma | 0 | 0 |
| 100 | 1 | 22 | 100 2003 LEUKEMIA & LYMPHOMA 44():S41-S47
Rosenwald A; Staudt LM Gene expression profiling of diffuse large B-cell lymphoma | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 101 | 2 | 58 | 101 2003 LEUKEMIA & LYMPHOMA 44():S63-S68
Little RF AIDS-related non-Hodgkin's lymphoma: Etiology, epidemiology, and impact of highly active antiretroviral therapy | 0 | 0 |
| 102 | 1 | 84 | 102 2003 MAYO CLINIC PROCEEDINGS 78(3):307-317
Ansell SM; Ackerman MJ; Black JL; Roberts LR; Tefferi A Primer on medical Genomics part VI: Genomics and molecular genetics in clinical practice | 0 | 0 |
| 103 | 1 | 58 | 103 2003 MODERN PATHOLOGY 16(5):471-480
Bai M; Agnantis NJ; Skyrlas A; Tsanou E; Kamina S; Galani V; Kanavaros P Increased expression of the bcl6 and CD10 proteins is associated with increased apoptosis and proliferation in diffuse large B-cell lymphomas | 1 | 1 |
| 104 | 1 | 83 | 104 2003 MOLECULAR AND CELLULAR BIOLOGY 23(5):1520-1533
Rayet B; Fan YJ; Gelinas C Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-KB-regulated cell death inhibitors important for v-Rel transforming activity | 0 | 3 |
| 105 | 1 | 39 | 105 2003 MOLECULAR BIOLOGY OF THE CELL 14(8):3208-3215
Chen X; Leung SY; Yuen ST; Chu KM; Ji JF; Li R; Chan ASY; Law S; Troyanskaya OG; Wong J; So S; Botstein D; Brown PO Variation in gene expression patterns in human gastric cancers | 0 | 0 |
| 106 | 2 | 54 | 106 2003 MOLECULAR CANCER THERAPEUTICS 2(10):1079-1084
Gardner SN; Fernandes M New tools for cancer chemotherapy: computational assistance for tailoring treatments | 0 | 0 |
| 107 | 1 | 12 | 107 2003 NATURE BIOTECHNOLOGY 21(5):491-492
Rangel-Aldao R Developing countries and systems biology | 0 | 0 |
| 108 | 3 | 166 | 108 2003 NATURE REVIEWS DRUG DISCOVERY 2(7):566-580
Frank R; Hargreaves R Clinical biomarkers in drug discovery and development | 0 | 1 |
| 109 | 1 | 100 | 109 2003 NATURE REVIEWS GENETICS 4(4):315-322
Muller M; Kersten S Nutrigenomics: goals and strategies | 0 | 11 |
| 110 | 2 | 40 | 110 2003 NEW ENGLAND JOURNAL OF MEDICINE 348(18):1777-1785
Staudt LM Molecular diagnosis of the hematologic cancers | 2 | 7 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 111 | 1 | 24 | 111 2003 ONCOGENE 22(9):1425-1429
Wessendorf S; Schwaenen C; Kohlhammer H; Kienle D; Wrobel G; Barth TFE; Nessling M; Moller P; Dohner H; Lichter P; Bentz M Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization | 0 | 2 |
| 112 | 1 | 30 | 112 2003 ONCOGENE 22(20):3076-3080
Carr KM; Bittner M; Trent JM Gene-expression profiling in human cutaneous melanoma | 0 | 0 |
| 113 | 1 | 123 | 113 2003 ONCOGENE 22(42):6497-6507
Russo G; Zegar C; Giordano A Advantages and limitations of microarray technology in human cancer | 0 | 0 |
| 114 | 1 | 29 | 114 2003 ONCOGENE 22(43):6810-6818
Takahashi M; Yang XMJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanyama H; Kagawa S; Teh BT Molecular subclassification of kidney tumors and the discovery of new diagnostic markers | 0 | 0 |
| 115 | 1 | 51 | 115 2003 ONCOGENE 22(44):6928-6936
Starczynowski DT; Reynolds JG; Gilmore TD Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells | 0 | 0 |
| 116 | 1 | 32 | 116 2003 ONCOLOGIST 8(3):252-258
Pusztai L; Ayers M; Stec J; Hortobagyi GN Clinical application of cDNA microarrays in oncology | 1 | 3 |
| 117 | 2 | 23 | 117 2003 PATHOLOGY RESEARCH AND PRACTICE 199(6):419-423
Hergenhahn M; Kenzelmann M; Grone HJ Laser-controlled microdissection of tissues opens a window of new opportunities | 0 | 0 |
| 118 | 1 | 31 | 118 2003 PATHOLOGY RESEARCH AND PRACTICE 199(6):425-430
Fend F; Kremer M; Specht K; Quintanilla-Martinez L Laser microdissection in hematopathology | 0 | 0 |
| 119 | 2 | 27 | 119 2003 PHARMACOGENOMICS JOURNAL 3(5):257-260
Covitz PA Class struggle: expression profiling and categorizing cancer | 0 | 0 |
| 120 | 1 | 18 | 120 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(4):1926-1930
Bohen SP; Troyanskaya OG; Alter O; Warnke R; Botstein D; Brown PO; Levy R Variation in gene expression patterns in follicular lymphoma and the response to rituximab | 0 | 3 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 121 | 1 | 27 | 121 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(14):8418-8423
Sorlie T; Tibshirani R; Parker J; Hastie T; Marron JS; Nobel A; Deng S; Johnsen H; Pesich R; Geisler S; Demeter J; Perou CM; Lonning PE; Brown PO; Borresen-Dale AL; Botstein D Repeated observation of breast tumor subtypes in independent gene expression data sets | 0 | 7 |
| 122 | 1 | 15 | 122 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(17):9991-9996
Wright G; Tan B; Rosenwald A; Hurt EH; Wiestner A; Staudt LM A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma | 4 | 4 |
| 123 | 2 | 18 | 123 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(19):10585-10587
Ferl GZ; Timmerman JM; Witte ON Extending the utility of gene profiling data by bridging microarray platforms | 0 | 0 |
| 124 | 1 | 105 | 124 2003 SEMINARS IN CANCER BIOLOGY 13(3):183-190
Viardot A; Barth TFE; Moller P; Dohner H; Bentz M Cytogenetic evolution of follicular lymphoma | 0 | 0 |
| 125 | 5 | 80 | 125 2003 SEMINARS IN HEMATOLOGY 40(4):296-307
Wiestner A; Staudt LM Towards molecular diagnosis and targeted therapy of lymphoid malignancies | 0 | 0 |
| 126 | 1 | 46 | 126 2003 TRENDS IN CARDIOVASCULAR MEDICINE 13(4):163-168
Patino WD; Mian OY; Shizukuda Y; Hwang PM Current and future applications of SAGE to cardiovascular medicine | 0 | 2 |
| 127 | 1 | 37 | 127 2003 TRENDS IN MOLECULAR MEDICINE 9(1):5-10
Hampton GM; Frierson HF Classifying human cancer by analysis of gene expression | 0 | 1 |
| 128 | 2 | 39 | 128 2003 ULTRASTRUCTURAL PATHOLOGY 27(5):289-294
Hicks J Genome, proteome, and metabolome: Where are we going? | 0 | 0 |
| 129 | 1 | 26 | 129 2004 AMERICAN JOURNAL OF PATHOLOGY 164(1):23-33
Rook MS; Delach SM; Deyneko G; Worlock A; Wolfe JL Whole genome amplification of DNA from laser capture-microdissected tissue for high-throughput single nucleotide polymorphism and short tandem repeat genotyping | 0 | 0 |
| 130 | 4 | 69 | 130 2004 BLOOD 103(1):275-282
Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Delabie J; Ott G; Muller-Hermelink HK; Campo E; Braziel RM; Jaffe ES; Pan ZG; Farinha P; Smith LM; Falini B; Banham AH; Rosenwald A; Staudt LM; Connors JM; Armitage JO; Chan WC Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 131 | 2 | 39 | 131 2004 LEUKEMIA 18(1):146-155
Simonitsch-Klupp I; Hauser I; Ott G; Drach J; Ackermann J; Kaufmann J; Weltermann A; Greinix HT; Skrabs C; Dittrich C; Lutz D; Potter R; Mannhalter C; Lechner K; Chott A; Jaeger U Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome | 0 | 0 |
| 132 | 1 | 24 | 132 2004 LEUKEMIA & LYMPHOMA 45(1):101-107
Maartense E; Kramer MHH; Le Cessie S; Kluin-Nelemans JC; Kluin PM; Snijder S; Noordijk EM Lack of prognostic significance of BCL2 and p53 protein overexpression in elderly patients with diffuse large B-cell non-Hodgkin's lymphoma: Results from a population-based non-Hodgkin's lymphoma registry | 0 | 0 |
| 133 | 1 | 29 | 133 2004 LEUKEMIA & LYMPHOMA 45(3):519-528
Au WY; Horsman DE; Gascoyne RD; Viswanatha DS; Klasa RJ; Connors JM The spectrum of lymphoma with 8q24 aberrations: A clinical, pathological and cytogenetic study of 87 consecutive cases | 0 | 0 |
| 134 | 1 | 46 | 134 2004 LEUKEMIA & LYMPHOMA 45(4):655-660
Hofmann WK; Komor M; Hoelzer D; Ottmann OG Mechanisms of resistance to STI571 (Imatinib) in Philadelphia-chromosome positive acute lymphoblastic leukemia | 0 | 0 |
Generated by: HistCite(Vlad).
Version: 2004.01.07